Higher normal ranges of urine albumin-to-creatinine ratio are independently associated with carotid intima-media thickness

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Kweon, Sun Seog ^a   Shin, Min Ho ^a   Lee, Young Hoon ^b   Choi, Jin Su ^a   Nam, Hae Sung ^c   Park, Kyeong Soo ^d   Kim, Do Hyung ^e   Jeong, Seul Ki ^e  

^a Chonnam National University Medical School   (South Korea)

^b Wonkwang University School of Medicine   (South Korea)

^c Chungnam National University   (South Korea)

^d Seonam University   (South Korea)

^e Chonbuk National University Medical School   (South Korea)

Author keywords

Albuminuria; Atherosclerosis; Carotid intima media thickness; Urine albumin to creatinine ratio

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGE; AGED; ALBUMIN TO CREATININE RATIO; ANALYTICAL PARAMETERS; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CREATININE URINE LEVEL; FEMALE; HUMAN; MALE; NORMAL VALUE; POPULATION RESEARCH; SEX DIFFERENCE; URINALYSIS;

AGED; ALBUMINURIA; BIOLOGICAL MARKERS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHI-SQUARE DISTRIBUTION; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 84866478719     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-112     Document Type: Article

References (42)

1. W.H.O Global burden of disease (GBD) 2004, WHO report, W.H.O.
2. Epidemiology of Diabetes Interventions and Complications (EDIC) Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care 1999, 22:99-111. 2745938, 10333910, Epidemiology of Diabetes Interventions and Complications (EDIC).
3. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspective. Kidney Int 2006, 69:2057-2063. 10.1038/sj.ki.5000377, 16612330.
4. Abdelhafiz AH, Ahmed S, El Nahas M. Microalbuminuria: marker or maker of cardiovascular disease. Nephron Exp Nephrol 2011, 119(Suppl 1):e6-e10.
5. Glassock RJ. Is the presence of microalbuminuria a relevant marker of kidney disease?. Curr Hypertens Rep 2010, 12:364-368. 10.1007/s11906-010-0133-3, 2941636, 20686930.
6. Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbiagele B. Impact of microalbuminuria on incident stroke: a meta-analysis. Stroke 2010, 41:2625-2631. 10.1161/STROKEAHA.110.581215, 20930164.
7. Miettinen H, Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke 1996, 27:2033-2039. 10.1161/01.STR.27.11.2033, 8898811.
8. Jessani S, Levey AS, Chaturvedi N, Jafar TH. High normal levels of albuminuria and risk of hypertension in Indo-Asian population. Nephrol Dial Transplant 2011,
9. Lee M, Saver JL, Chang KH, Ovbiagele B. Level of albuminuria and risk of stroke: systematic review and meta-analysis. Cerebrovasc Dis 2010, 30:464-469. 10.1159/000317069, 2992641, 20733300.
10. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts a collaborative meta-analysis. Lancet 2010, 375:2073-2081. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts.
11. Polak JF, Backlund JY, Cleary PA, Harrington AP, O'Leary DH, Lachin JM, Nathan DM. Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes 2011, 60:607-613. 10.2337/db10-0296, 3028362, 21270271.
12. Mykkanen L, Zaccaro DJ, O'Leary DH, Howard G, Robbins DC, Haffner SM. Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. The Insulin Resistance Atherosclerosis Study (IRAS). Stroke 28, 28:1710-1716.
13. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007, 115:459-467. 10.1161/CIRCULATIONAHA.106.628875, 17242284.
14. Nam HS, Shin MH, Zmuda JM, Leung PC, Barrett-Connor E, Orwoll ES, Cauley JA. Race/ethnic differences in bone mineral densities in older men. Osteoporos Int 2010, 21:2115-2123. 10.1007/s00198-010-1188-3, 2974925, 20204598.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419. 10.1007/BF00280883, 3899825.
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
17. Choi SW, Kim HY, Lee YH, Ryu SY, Kweon SS, Rhee JA, Choi JS, Shin MH. eGFR is associated with subclinical atherosclerosis independent of albuminuria: The Dong-gu Study. Atherosclerosis 2010, 212:661-667. 10.1016/j.atherosclerosis.2010.06.039, 20667408.
18. Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Doi Y, Okubo K, Wakugawa Y, Hata J, Oishi Y, Shikata K, Yonemoto K, Hirakata H, Iida M. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int 2005, 68:228-236. 10.1111/j.1523-1755.2005.00397.x, 15954912.
19. Sung JK, Kim JY, Youn YJ, Lee JW, Ahn SG, Yoo BS, Lee SH, Yoon J, Choe KH, Yoon JH, Park JK, Koh SB. Urine albumin creatinine ratio is associated with carotid atherosclerosis in a community based cohort: atherosclerosis risk of rural area in Korean general population study. J Cardiovasc Ultrasound 2010, 18:134-138. 10.4250/jcu.2010.18.4.134, 3021891, 21253362.
20. Yu Z, Schneck M, Jacobs DR, Liu K, Allison M, O'Leary D, Durazo R, Darwin C, Kramer H. Association of carotid intima-media thickness with progression of urine albumin-creatinine ratios in The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 2011, 57:62-70. 10.1053/j.ajkd.2010.08.014, 20974513.
21. Wang G, Lai FM, Lai KB, Chow KM, Kwan BC, Li PK, Szeto CC. Urinary messenger RNA expression of podocyte-associated molecules in patients with diabetic nephropathy treated by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker. Eur J Endocrinol 2008, 158:317-322. 10.1530/EJE-07-0708, 18299464.
22. Ito H, Komatsu Y, Mifune M, Antoku S, Ishida H, Takeuchi Y, Togane M. The estimated GFR, but not the stage of diabetic nephropathy graded by the urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study. Cardiovasc Diabetol 2010, 9:18. 10.1186/1475-2840-9-18, 2877657, 20470427.
23. Stehouwer CDA, Gall M-A, Twisk JWR, Knudsen E, Emeis JJ, Parving H-H. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes. Diabetes 2002, 51:1157-1165. 10.2337/diabetes.51.4.1157, 11916939.
24. Juonala M, Viikari JS, Laitinen T, Marniemi J, Helenius H, Ronnemaa T, Raitakari OT. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study. Circulation 2004, 110:2918-2923. 10.1161/01.CIR.0000147540.88559.00, 15505080.
25. Pontremoli R, Leoncini G, Viazzi F, Parodi D, Ratto E, Vettoretti S, Ravera M, Tomolillo C, Deferrari G. Cardiovascular and renal risk assessment as a guide for treatment in primary hypertension. J Am Soc Nephrol 2004, 15(Suppl 1):S34-S36.
26. Katakami N, Kim YS, Kawamori R, Yamasaki Y. The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study: a randomized trial. Circulation 2010, 121:2584-2591. 10.1161/CIRCULATIONAHA.109.892414, 20516379.
27. Epstein M, Williams GH, Weinberger M, Lewin A, Krause S, Mukherjee R, Patni R, Beckerman B. Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes. Clin J Am Soc Nephrol 2006, 1:940-951. 10.2215/CJN.00240106, 17699311.
28. Yanagawa T, Araki A, Sasamoto K, Shirabe S, Yamanouchi T. Effect of antidiabetic medications on microalbuminuria in patients with type 2 diabetes. Metabolism 2004, 53:353-357. 10.1016/j.metabol.2003.10.025, 15015149.
29. Fredrickson SK, Ferro TJ, Schutrumpf AC. Disappearance of microalbuminuria in a patient with type 2 diabetes and the metabolic syndrome in the setting of an intense exercise and dietary program with sustained weight reduction. Diabetes Care 2004, 27:1754-1755. 10.2337/diacare.27.7.1754, 15220261.
30. Stumpe KO, Agabiti-Rosei E, Zielinski T, Schremmer D, Scholze J, Laeis P, Schwandt P, Ludwig M. Carotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) study. Ther Adv Cardiovasc Dis 2007, 1:97-106. 10.1177/1753944707085982, 19124398.
31. Zhao B, Liu Y, Zhang Y, Chen Y, Yang Z, Zhu Y, Zhan W. Gender difference in carotid intima-media thickness in type 2 diabetic patients: a 4-year follow-up study. Cardiovasc Diabetol 2012, 11:51. 10.1186/1475-2840-11-51, 3398844, 22583598.
32. Den Ruijter HM, Peters SA, Anderson TJ, Britton AR, Dekker JM, Eijkemans MJ, Engstrom G, Evans GW, de Graaf J, Grobbee DE, Hedblad B, Hofman A, Holewijn S, Ikeda A, Kavousi M, Kitagawa K, Kitamura A, Koffijberg H, Lonn EM, Lorenz MW, Mathiesen EB, Nijpels G, Okazaki S, O'Leary DH, Polak JF, Price JF, Robertson C, Rembold CM, Rosvall M, Rundek T, et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA 2012, 308:796-803. 10.1001/jama.2012.9630, 22910757.
33. Nishida Y, Takahashi Y, Nakayama T, Soma M, Asai S. Comparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational study. Cardiovasc Diabetol 2011, 10:74. 10.1186/1475-2840-10-74, 3163179, 21827713.
34. Keidar S, Kaplan M, Hoffman A, Aviram M. Angiotensin II stimulates macrophage-mediated oxidation of low density lipoproteins. Atherosclerosis 1995, 115:201-215. 10.1016/0021-9150(94)05514-J, 7661879.
35. Eknoyan G. Obesity and chronic kidney disease. Nefrologia 2011, 31:397-403.
36. Mattix HJ, Hsu CY, Shaykevich S, Curhan G. Use of the albumin/creatinine ratio to detect microalbuminuria: implications of sex and race. J Am Soc Nephrol 2002, 13:1034-1039.
37. Cirillo M, Laurenzi M, Mancini M, Zanchetti A, De Santo NG. Low muscular mass and overestimation of microalbuminuria by urinary albumin/creatinine ratio. Hypertension 2006, 47:56-61.
38. Rocco A, Heerlein K, Diedler J, Sykora M, Barrows R, Hacke W, Steiner T. Microalbuminuria in cerebrovascular disease: a modifiable risk factor?. Int J Stroke 2010, 5:30-34.
39. Knopman DS. Invited commentary: Albuminuria and microvascular disease of the brain--a shared pathophysiology. Am J Epidemiol 2010, 171:287-289. author reply 290-281, 10.1093/aje/kwp429, 2842197, 20061365.
40. Barzilay JI, Gao P, O'Donnell M, Mann JF, Anderson C, Fagard R, Probstfield J, Dagenais GR, Teo K, Yusuf S. Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies. Arch Intern Med 2011, 171:142-150. 10.1001/archinternmed.2010.502, 21263104.
41. Kurella Tamura M, Muntner P, Wadley V, Cushman M, Zakai NA, Bradbury BD, Kissela B, Unverzagt F, Howard G, Warnock D, McClellan W. Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States. Am J Kidney Dis 2011, 58:756-763. 10.1053/j.ajkd.2011.05.027, 3199339, 21816528.
42. Sajjad I, Grodstein F, Kang JH, Curhan GC, Lin J. Kidney dysfunction and cognitive decline in women. Clin J Am Soc Nephrol 2012, 7:437-443. 10.2215/CJN.05330611, 22241818.